Lv21
176 积分 2022-05-11 加入
Efficacy and safety of low-dose interleukin 2 in the treatment of moderate-to-severe bullous pemphigoid: A single center perspective-controlled trial
1个月前
已完结
Low-dose interleukin-2 in the treatment of refractory relapsing polychondritis
1个月前
已完结
Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up
1个月前
已完结
Cancer incidence and mortality in China, 2022
1个月前
已完结
Hypersensitivity and Immune-related Adverse Events in Biologic Therapy
1个月前
已完结
Injection site reactions with the use of biological agents
1个月前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
4个月前
已完结
Chronic Urticaria and Angioedema
5个月前
已完结
Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines
6个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
6个月前
已完结
皖公网安备34019202002308
